By many measures, the US leads the world in biomedical discoveries, technologies and therapies. Recombinant DNA technologies for genetic manipulation were born in America and have produced a multitude of drugs and diagnostic devices by means of a new commercial entity, the biotech startup.
At a critical stage in US history, federal and local governments nearly banned recombinant DNA technology. But instead new regulations required academic and commercial research entities to submit their plans for approval to national and local advisory committees - and research prospered.
